Mark Sullivan III, Chief Legal Officer at Definium Therapeutics, Inc. (DFTX), sold 10,702 shares at $18.47 ($198K) on 2026-03-25, disclosed to the SEC on 2026-03-26.
Scheduled sale ($198k) by Chief Legal Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| MNMD | SELL | 2025-09-26 | $220K | — | Filing → |
| MNMD | SELL | 2025-06-26 | $156K | — | Filing → |
| MNMD | SELL | 2025-03-26 | $44K | — | Filing → |